On World Lymphoma Awareness Day, we would like to acknowledge and thank everyone who has helped and supported Australian Lymphoma patients on what can be a difficult and challenging journey.
Despite Lymphoma being the 6th most common cancer with over * 80 different subtypes we often feel that we are the forgotten cancer. However, over the last decade, research, clinical trials, and the tireless work of our clinicians, nurses, patients and caregivers has resulted in Australian patients having access to many new medicines.
On the eve of World Lymphoma Day 2018 our Health Minister, Greg Hunt MP, announced that Gazyva will be available in Australia for eligible Non-Hodgkin Lymphoma Follicular patients from the 1st of October.
This now gives us a grand total of 12 new treatments that have been approved for the PBS by the government for Australian patients over the last 2 years. (This also incudes some very rare sub types).
Clinical trials and access to new medicines gives patients hope for the future and we will continue to advocate for the gold standard of care for our Australian patients.
Blood cancer drugs added to PBS: https://www.9news.com.au/national/2018/09/14/21/38/pbs-affordable-blood-cancer-drugs
